Evaxion Biotech AS (EVAX)
3.97
+0.06
(+1.53%)
USD |
NASDAQ |
May 02, 14:23
Evaxion Biotech Net Income (TTM): -22.12M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -22.12M |
| September 30, 2023 | -24.47M |
| June 30, 2023 | -24.54M |
| March 31, 2023 | -23.62M |
| December 31, 2022 | -23.17M |
| September 30, 2022 | -24.67M |
| June 30, 2022 | -24.18M |
| Date | Value |
|---|---|
| March 31, 2022 | -26.23M |
| December 31, 2021 | -24.53M |
| September 30, 2021 | -20.43M |
| June 30, 2021 | -19.19M |
| March 31, 2021 | -16.01M |
| December 31, 2020 | -15.02M |
| September 30, 2020 | -14.27M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-26.23M
Minimum
Mar 2022
-14.27M
Maximum
Sep 2020
-21.60M
Average
-23.40M
Median
Net Income (TTM) Benchmarks
| Ascendis Pharma A/S | -521.73M |
| DBV Technologies SA | -72.73M |
| Cellectis SA | -101.07M |
| Adaptimmune Therapeutics PLC | -113.87M |
| Akari Therapeutics PLC | -10.01M |